28416598|t|EBV MicroRNA BART16 Suppresses Type I IFN Signaling
28416598|a|Type I IFNs play critical roles in orchestrating the antiviral defense by inducing direct antiviral activities and shaping the adaptive immune response. Viruses have evolved numerous strategies to specifically interfere with IFN production or its downstream mediators, thereby allowing successful infection of the host to occur. The prototypic human gammaherpesvirus EBV, which is associated with infectious mononucleosis and malignant tumors, harbors many immune-evasion proteins that manipulate the adaptive and innate immune systems. In addition to proteins, the virus encodes >40 mature microRNAs for which the functions remain largely unknown. In this article, we identify EBV - encoded miR-BART16 as a novel viral immune-evasion factor that interferes with the type I IFN signaling pathway. miR-BART16 directly targets CREB-binding protein, a key transcriptional coactivator in IFN signaling, thereby inducing CREB-binding protein downregulation in EBV-transformed B cells and gastric carcinoma cells. miR-BART16 abrogates the production of IFN - stimulated genes in response to IFN-α stimulation and it inhibits the antiproliferative effect of IFN-α on latently infected BL cells. By obstructing the type I IFN - induced antiviral response, miR-BART16 provides a means to facilitate the establishment of latent EBV infection and enhance viral replication.
28416598	0	3	EBV	T005	C0014644
28416598	4	19	MicroRNA BART16	T114,T123	C1101610
28416598	20	30	Suppresses	T169	C1260953
28416598	31	51	Type I IFN Signaling	T043	C2610474
28416598	52	63	Type I IFNs	T116,T121,T129	C0021743
28416598	87	100	orchestrating	T169	C1300196
28416598	105	122	antiviral defense	T040	C1155328
28416598	126	134	inducing	T169	C0205263
28416598	142	162	antiviral activities	T040	C1155328
28416598	167	174	shaping	T082	C0332479
28416598	179	203	adaptive immune response	T040	C1749719
28416598	205	212	Viruses	T005	C0042776
28416598	262	276	interfere with	T169	C0521102
28416598	277	291	IFN production	T040	C1819430
28416598	299	319	downstream mediators	T129	C0021054
28416598	349	358	infection	T046	C3714514
28416598	366	370	host	T001	C1167395
28416598	374	379	occur	T052	C1709305
28416598	396	418	human gammaherpesvirus	UnknownType	C0682456
28416598	419	422	EBV	T005	C0014644
28416598	433	448	associated with	T080	C0332281
28416598	449	473	infectious mononucleosis	T047	C0021345
28416598	478	494	malignant tumors	T191	C0006826
28416598	496	503	harbors	T078	C3154893
28416598	509	523	immune-evasion	T040	C1654934
28416598	524	532	proteins	T116,T123	C0033684
28416598	553	561	adaptive	T039	C0678209
28416598	566	572	innate	T032	C0020969
28416598	573	587	immune systems	T022	C0020962
28416598	604	612	proteins	T116,T123	C0033684
28416598	618	623	virus	T005	C0042776
28416598	643	652	microRNAs	T114,T123	C1101610
28416598	667	676	functions	T169	C0542341
28416598	721	729	identify	T080	C0205396
28416598	730	733	EBV	T005	C0014644
28416598	736	743	encoded	T052	C2700640
28416598	744	754	miR-BART16	T114,T123	C1101610
28416598	766	771	viral	T169	C0521026
28416598	772	786	immune-evasion	T040	C1654934
28416598	787	793	factor	T169	C1521761
28416598	799	809	interferes	T169	C0521102
28416598	819	847	type I IFN signaling pathway	T043	C2610474
28416598	849	859	miR-BART16	T114,T123	C1101610
28416598	877	897	CREB-binding protein	T116	C0256079
28416598	905	932	transcriptional coactivator	T116,T123	C1336776
28416598	936	949	IFN signaling	T039	C1512827
28416598	959	967	inducing	T169	C0205263
28416598	968	988	CREB-binding protein	T116	C0256079
28416598	989	1003	downregulation	T044	C0013081
28416598	1007	1030	EBV-transformed B cells	T025	C2699839
28416598	1035	1058	gastric carcinoma cells	T191	C1333789
28416598	1060	1070	miR-BART16	T114,T123	C1101610
28416598	1085	1095	production	T169	C0005572
28416598	1099	1102	IFN	T116,T121,T129	C0021747
28416598	1105	1115	stimulated	T044	C0038337
28416598	1116	1121	genes	T028	C0017337
28416598	1125	1133	response	T032	C0871261
28416598	1137	1142	IFN-α	T116,T121,T129	C0002199
28416598	1143	1154	stimulation	T044	C0038337
28416598	1162	1170	inhibits	T080	C0311403
28416598	1175	1192	antiproliferative	T109,T121	C0003392
28416598	1193	1199	effect	T080	C1280500
28416598	1203	1208	IFN-α	T116,T121,T129	C0002199
28416598	1212	1220	latently	T080	C0205275
28416598	1221	1229	infected	T033	C0439663
28416598	1230	1238	BL cells	T025	C0004561
28416598	1259	1269	type I IFN	T116,T121,T129	C0021743
28416598	1272	1279	induced	T169	C0205263
28416598	1280	1298	antiviral response	T040	C1155328
28416598	1300	1310	miR-BART16	T114,T123	C1101610
28416598	1363	1369	latent	T080	C0205275
28416598	1370	1373	EBV	T005	C0014644
28416598	1374	1383	infection	T046	C3714514
28416598	1388	1395	enhance	T052	C2349975
28416598	1396	1413	viral replication	T043	C0042774